Metabolic consequences in very low birth weight infants transfused with older AS-1-preserved erythrocytes

Pediatric Pathology and Molecular Medicine

Volumn 18, Issue 2, 1998, Pages 173-185

  Goodstein, Michael H ^a,b   Herman, Jay H ^c   Smith, Janis F ^d   Rubenstein, S David ^e  

^a YORK HOSPITAL   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d AMERICAN RED CROSS   (United States)

^e NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Additive solution 1 (AS 1); Dedicated unit; Packed red blood cells (PRBC); Transfusion; Very low birth weight (VLBW)

Indexed keywords

ACID BASE BALANCE; AMMONIA BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; ERYTHROCYTE TRANSFUSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; LACTATE DEHYDROGENASE BLOOD LEVEL; LOW BIRTH WEIGHT; METABOLISM; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; URINE VOLUME;

EID: 0032322065     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/152279598308119     Document Type: Article

References (27)

1. Pisciotto P, ed. Blood Transfusion Therapy. A Physician's Handbook. 4th ed. Bethesda: American Association of Blood Banks, 1993;65.
2. Shannon KM, Keith JF, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, Gleeson CA, Bitano EM, Millard DD, Davis CB, Stevenson DK, Alverson DC, Simmons CF, Brim M, Abels RI, Phibbs RH. Recombinant human erythropoietin stimulate erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95:1-8.
3. Wilimas JA, Crist WM. Erythropoietin - not yet a standard treatment for anemia of prematurity [commentary]. Pediatrics 1995;95:9-10.
4. Maier RF, Obladen MO, Scigalla P, Linderkamp O, Duc G, Hieronimi G, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 1994;330:1173-1178.
5. Messer J, Haddad J, Donato L, Astruc D, Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993;92:519-523.
6. Liu EA, Mannino FL, Lane TA. Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates. J Pediatr 1994;125:92-96.
7. Lee DA, Slagle TA, Jackson TM, Evans CS. Reducing blood donor exposures in low birth weight infants by the use of older unwashed packed red blood cells. J Pediatr 1995;126:280-286.
8. Wang-Rodriguez J, Mannino FL, Liu E, Lane TA. A novel strategy to limit blood donor exposure and blood waste in multiply transfused premature infants. Transfusion 1996;36:64-70.
9. Wood A, Wilson N, Skacel P, Thomas R, Tidmarsh E, Yale C, de Silva M. Reducing donor exposure in preterm infants requiring multiple blood transfusions. Transfusion 1995;72:F29-F33.
10. Strauss RG, Burmeister LF, Johnson K, James T, Miller J, Cordle DG, et al. AS-1 red cells for neonatal transfusions: A randomized trial assessing donor exposure and safety. Transfusion 1996;36:873-878.
11. Heaton A, Miripol J, Aster R, Hartman P, Dehart D, Rzad DL, et al. Use of Adsol preservation solution for prolonged storage of low-viscosity AS-1 red blood cells. Br J Haematol 1984;57:467-478.
12. Hogman CF, Akerblom O, Hedlund K, Rosen I, Wiklund L. Red cell suspensions in SAGM medium: Further experience of in vivo survival of red cells, clinical usefulness, and plasma saving effects. Vox Sang 1983;45:217-223.
13. Goodstein MH, Locke RG, Wlodarczyk D, Goldsmith LS, Rubenstein SD, Herman JH. Comparison of two preservation solutions for erythrocyte transfusions in newborn infants. J Pediatr 1993;123:783-788.
14. Walker R, ed. Technical Manual, 11th ed. Bethesda: American Association of Blood Banks, 1993;721-722.
15. Moroff G, Dende D. Characterization of biochemical changes occurring during storage of red cells: comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions. Transfusion 1983;23:484-489.
16. Patten E, Robbins M, Vincent J, Richardson J, Hokanson J. Use of red blood cells older than five days for neonatal transfusion. J Perinatology 1990;11:37-40.
17. Hall TL, Barnes A, Miller JR, Bethencourt DM, Nestor L. Neonatal mortality following transfusion of red cells with high plasma potassium levels. Transfusion 1993;33:606-609.
18. Brion LP, Satlin LM, Edelmann CM. Renal Disease. In Avery GB, Fletcher MA, MacDonald MG, eds. Neonatology: Pathophysiology and Management of the Newborn. 4th ed. Philadelphia : JB Lippincott, 1994;800.
19. Micheli JL, Schutz Y. Protein. In Tsang RG, Lucas A, Uauy R, Zlotkin S, eds. Nutritional Needs of the Preterm Infant. Baltimore: Williams & Wilkins, 1993;38.
20. Sanchez R, Ukrainski C, Perlin B, Farber S, Goldfinger D, Pomerance J. Hyperammonemia in low birth weight infants. Pediatr Res 1978;12:534A.
21. Rubin RJ, Ness PM. What price progress? An update on vinyl plastic blood bags. Transfusion 1989;29:358-361.
22. Meites S. Pediatric Clinical Chemistry. Washington, D.C.: American Association for Clinical Chemistry, 1981;95.
23. Usmani SS, Cavaliere T, Casatelli J, Harper G. Plasma ammonia levels in very low birth weight infants. J Pediatr 1993;123:797-800.
24. Avery GB, Fletcher MA, MacDonald MG, eds. Neonatology: Pathophysiology and Management of the Newborn. 4th ed. Philadelphia: JB Lippincott, 1994;1391.
25. Strauss RG, Sacher RA, Blazina JF, Blanchette VS, Schloz LM, Butch SH, Hume H, Levy GJ, McMilan A, Sotelo-Avila C. Commentary on small-volume red cell transfusions for neonatal patients. Transfusion 1990;30:565-570.
26. Valeri CR, Valeri DA, Gray A, Melaragno A, Dennis RC, et al. Viability and function of red blood cell concentrate stored at 4°C for 35 days in CPDA-1, CPDA-2, or CDPD-3. Transfusion 1982;22:210-216.
27. Beutler E, Wood L. The in vivo regeneration of red cell 2,3-DPG after transfusion of stored blood. J Lab Clin Med 1969;74:300-304.